Summary
The therapeutic effects of anluohuaxian tablet combined with γ-IFN on schistosomal liver fibrosis and its mechanism were studied in a murine model and clinical cases of schistosomal liver fibrosis. Fifty Kunming mice were randomly divided into 5 groups: normal control group, infection control group, anluohuaxian tablet-treated group, γ-IFN-treated group and combined treatment (anluohuaian tablet+γ-IFN) group. Pathologic changes in liver, including hepatic pigmentation and the size of schistosomal egg granuloma, were observed by HE staining after treatment for 8 weeks. The expression of the type I and collagen III, and TIMP-1 was detected by immunohistochemistry. TGF-β1 mRNA expression was examined by real-time fluorescent quantitative PCR. Sixty patients with schistosomal liver fibrosis were divided into treatment group and control group. The patients in treatment group were treated with anluohuaxian tablet in combination with γ-IFN for 6 months. Before and after treatment, the changes of symptoms and signs, liver function, serum liver fibrosis indexes and imaging indexes were observed. The results showed that as compared with infection control group, all forms of treatments relieved the hepatic pathological injury with apparently diminished size of schistosomal egg nodules and decreased percentage of pigmentation (P<0.05). Furthermore, the expression of collagen I and III, TIMP-1, and TGF-β1 mRNA in combined treatment group was significantly decreased as compared with anluohuaxian tablet-treated and γ-IFN-treated groups (P<0.05). In the clinical observation, the serum liver fibrosis indexes, the portal vein width as well as the spleen thickness was significantly reduced in treatment group as compared with control group (P<0.05). It was concluded that the combined use of anluohuaxian tablet with γ-IFN in schistosomal liver fibrosis could protect liver function, alleviate liver fibrosis, and could be used as a choice in treating patients with schiatosomal liver fibrosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weng HL, Cai WM, Wang BE, et al. Clinical study of anti-hepatic fibrosis effect of γ-IFN in patients with chronic hepatitis B. Chin Med J (Chinese), 2003,83(11):943–947
Cheng GZ, Mao DW, Li GX, et al. Effects of Anluohuaxian capsule on hepatic fibrosis indexes in patients with chronic hepatitis. Chin J Integ Tradit Western Med Dig (Chinese), 2005,13(2):1099
National Standard GB15977-1995 (China). Diagnostic criteria and principles of management of schistosomiasis[S]
Hepatic fibrosis Group under Chinese Liver Disease Association. Common understanding of diagnosis and effect of hepatic fibrosis. Chin J Hepatol (Chinese), 2002,10(5):327–328
Wu WL, Cai WM, Chen MG, et al. Blueprint for the diagnosis and assessment of therapeutic efficacy in liver fibrosis due to schistosomiasis. Chin J Schistosomiasis Control (Chinese), 2004,16(3):229–230
Friedman SL. Liver fibrosis—from bench to bedside. J Hepatol, 2003,38(Supp l1):38
Wu WL, Zhou XZ, Huang YY, et al. Long-term efficacy of pyquiton on Schistosomiasis japonica. Chin J Infect Dis (Chinese), 2004,22(4):238–241
Bataller R, Brenner DA. Liver fibrosis. J Clin Invest, 2005,1(2):209–218
Shek FW, Benyon RC. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? J Eur J Gastro Enterol Hepato, 2004,16(2):123–126
Herbs TH, Wege T, Milani S, et al. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol, 1997,150: 1647–1659
Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem, 2002,277:11 069–11 076
Chen XB, Wu GL, Sun X, et al. Modern Parasitology (Chinese). Beijing: People’s Military Medical Press, 2002.638
Ma H, Zhu YK, Ma XM, et al. Effects of γ-interferon on gene expression of collagen I, III and tissue inhibito of metalloproteinase 1 in dimethylnitrosamine-induced liver fibrosis in rats. Chin Hepatol, 2005,10:92–94
Tao J, Cai WM, Zhang BB, et al. Pigment deposit in liver of BALB/c mice infected by Schistosoma japonicum and its relation to the effect of praziquantel treatment. Chin J Parasitol Parasitic Dis (Chinese), 2006,24(1):79–80
Hurst MH, Willingham AL 3rd, Lindberg R. Tissue responses in experimental schistosomiasis japonica in the pig: a histopathologic study of different stages of single low- or high-dose infections. Am J Trop Med Hyg, 2000,62(1):45–50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huang, J., Huang, H., Jiao, Y. et al. Effect of anluohuaxian tablet combined with γ-IFN on schistosomal liver fibrosis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 53–58 (2009). https://doi.org/10.1007/s11596-009-0111-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-009-0111-7